79th World Health Assembly Approves Global Equity Resolution – EHC
European Haemophilia Consortiumn (EHC), shared a post on LinkedIn:
“The 79th World Health Assembly has adopted a landmark resolution on ‘Global action to advance health equity for people with haemophilia and other bleeding disorders’.
This is a major step toward improving earlier diagnosis, ensuring equitable access to care and treatment, recognising women and girls with bleeding disorders, and strengthening national health systems for rare bleeding disorders worldwide.
In Europe, significant disparities in access to diagnosis, treatment, and comprehensive care persist both between and within countries.
The European Union (EU) has a critical role to play in closing these gaps.
The European Haemophilia Consortium (EHC) calls on the EU and its Member States to translate this global commitment into concrete action by strengthening rare disease policies, ensuring sustainable and equitable access to innovative therapies, and supporting coordinated, high-quality care across Europe.
EHC welcomes this momentum and stands with the international community in advancing sustainable, inclusive, and patient-centred care across Europe and beyond!”
Other posts featuring EHC on Hemostasis Today.
-
May 26, 2026, 03:02Spelile Mutupira: Process of Blood Clotting After Injury
-
May 26, 2026, 03:00Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?
-
May 26, 2026, 02:58Toriqul Islam: EDTA-Induced Pseudothrombocytopenia
-
May 26, 2026, 02:34James O’Donnell Secures 2 Million Euros for a New Programme on The Irish ABO and Coagulation Study – RCSI
-
May 26, 2026, 02:26Joseph R. Shaw: Join The Annual CanVECTOR National Thrombosis Seminar on Precision in DOAC Reversal
-
May 26, 2026, 01:42Mili Doshi: The Role of Oral Health Teams in Supporting Stroke Rehabilitation and Recovery
-
May 26, 2026, 01:25Mohamed Mamdouh: Advancing Stroke Care Access in Cairo Through the Launch of a New Stroke-Ready Center
-
May 26, 2026, 01:15Tom Lazenby: Accelerating Rare Disease Drug Development Through MHRA’s Investigational Marketing Authorisation
-
May 25, 2026, 22:15Cedric Hermans: What Is Still To Be Discovered and To Be Redefined in The Treatment of Haemophilia A?